Document:

Exhibit 10.3 

 

Xilio
Therapeutics, Inc.

 

Stock
Option Agreement 

Granted
Under 2020 Stock Incentive Plan

 

This Stock Option
Agreement (this “Agreement”) is made between Xilio Therapeutics, Inc., a Delaware corporation (the “Company”),
and the Participant pursuant to the 2020 Stock Incentive Plan (the “Plan”).

 

Notice
of Grant

 

I.             Participant
Information

	Participant:	 
	Participant
    Address:	 

 

II.            Grant
Information

	Grant
    Date:	 
	Number
    of Shares:	 
	Exercise
    Price Per Share:	 
	Vesting
    Commencement Date:	 
	Type
    of Option:	[Incentive
    Stock Option][Nonstatutory Stock Option]

 

III.           Vesting
Table1

	Vesting
    Date	Shares
    that Vest(1)
	[____]
    anniversary of the Vesting Commencement Date	[#
    of shares]
	End
    of each successive [__] month period following the [____] anniversary of the Vesting Commencement Date until the [____] anniversary
    of the Vesting Commencement Date	[#
    of Shares]

(1) 
The number of shares is subject to adjustment for any changes in the Company’s capitalization as set forth in Section 9 of
the Plan.

 

IV.           Final
Exercise Date

	5:00
    pm Eastern time on Date:	[Date
    is ten years minus one day from Grant Date]

 

This Agreement includes
this Notice of Grant and the following Exhibits, which are expressly incorporated by reference in their entirety herein:

 

Exhibit A – General Terms and
Conditions

Exhibit B – Notice of Stock
Option Exercise

Exhibit C – Xilio Therapeutics, Inc.
2020 Stock Incentive Plan

 

 

1 Vesting Table to reflect vesting
schedule approved by Board of Directors.

 

     

     

    

 

IN WITNESS WHEREOF, the parties hereto
have executed this Agreement.

 

	XILIO THERAPEUTICS, INC.	 	PARTICIPANT	 	SPOUSAL CONSENT2
	 	 	 	 	 
	Name: 
Title:	 	Name:	 	Name:

 

 

2
If the Participant resides in a community property state, it is desirable to have the Participant’s spouse also accept the
option. The following are community property states: Arizona, California, Idaho, Louisiana, Nevada, New Mexico, Texas, and Washington.
Although Wisconsin is not formally a community property state, it has laws governing the division of marital property similar to community
property states and it may be desirable to have a Wisconsin Participant’s spouse accept the option.

 

    - 2 -

     

    

 

Exhibit A

 

General
terms and Conditions

 

For valuable consideration,
receipt of which is acknowledged, the parties hereto agree as follows:

 

1.              Grant
of Option. This Agreement evidences the grant by the Company, on the grant date (the “Grant Date”) set forth in
the Notice of Grant that forms part of this Agreement (the “Notice of Grant”), to the Participant of an option to
purchase, in whole or in part, on the terms provided herein and in the Company’s 2020 Stock Incentive Plan (the “Plan”),
the number of shares set forth in the Notice of Grant (the “Shares”) of common stock, $0.0001 par value per share,
of the Company (“Common Stock”) at the exercise price per Share set forth in the Notice of Grant (the “Exercise
Price”). Unless earlier terminated, this option shall expire at the time and on the date set forth in the Notice of Grant (the
 “Final Exercise Date”).

 

It
is intended that the option evidenced by this Agreement shall be an incentive stock option as defined in Section 422 of the Internal
Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”) solely to the extent set
forth in the Notice of Grant. To the extent not designated as an incentive stock option, or to the extent that the option does not qualify
as an incentive stock option, the option shall be a nonstatutory stock option. Except as otherwise indicated by the context, the term
 “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option
validly under its terms.

 

2.             Vesting
Schedule. This option will become exercisable (“vest”) in accordance with the Vesting Table set forth in the Notice
of Grant.

 

The
right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible
it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the
Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.

 

3.              Exercise
of Option.

 

(a)              Form of
Exercise. Each election to exercise this option shall be accompanied by a completed Notice of Stock Option Exercise in the form attached
hereto as Exhibit B, signed by the Participant, and received by the Company at its principal office, accompanied by this
Agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of Shares covered
hereby, provided that no partial exercise of this option may be for any fractional share or for fewer than ten whole shares (unless the
number of Shares that remain subject to this option at the time of exercise is less than ten whole shares, in which case the Participant
may purchase the total number of whole shares that remain subject to this option).

 

(b)              Continuous
Relationship with the Company Required. Except as otherwise provided in this Section 3, this option may not be exercised unless
the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee, officer
or director of, or consultant or advisor to, the Company or any parent or subsidiary of the Company as defined in Section 424(e) or
(f) of the Code or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive
option grants under the Plan (an “Eligible Participant”).

 

    - 3 -

     

    

 

(c)              Termination
of Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided
in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but
in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant
was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final
Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure
agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon
such violation.

 

(d)              Exercise
Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of
the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such service
relationship for “cause” as specified in paragraph (e) below, this option shall be exercisable, within the period
of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized
transferee), provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on
the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date.

 

(e)              Termination
for Cause. If, prior to the Final Exercise Date, the Participant’s service relationship with the Company is terminated by the
Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination.
If, prior to the Final Exercise Date, the Participant is given notice by the Company of the termination of his or her service relationship
by the Company for Cause, and the effective date of such termination is subsequent to the date of the delivery of such notice, the right
to exercise this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it
is determined or otherwise agreed that the Participant’s service relationship shall not be terminated for Cause as provided in
such notice or (ii) the effective date of such termination (in which case the right to exercise this option shall, pursuant to the
preceding sentence, terminate immediately upon the effective date of such termination). If the Participant is party to an employment,
consulting or severance agreement with the Company or subject to a severance plan maintained by the Company, in either case, that contains
a definition of “cause” for termination of service, “Cause” shall have the meaning ascribed to such term in such
agreement or plan. Otherwise, “Cause” shall mean willful misconduct by the Participant or willful failure by the Participant
to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any
employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company),
as determined by the Company, which determination shall be conclusive. The Participant’s service relationship shall be considered
to have been terminated for “Cause” if the Company determines, within 30 days after the Participant’s termination of
service, that termination for Cause was warranted.

 

    - 4 -

     

    

 

4.              Company
Right of First Refusal.

 

(a)              Notice
of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation
of law or otherwise (collectively, “transfer”) any Shares acquired upon exercise of this option, then the Participant
shall first give written notice of the proposed transfer (the “Transfer Notice”) to the Company. The Transfer Notice
shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the “Offered Shares”),
the price per share and all other material terms and conditions of the transfer.

 

(b)              Company
Right to Purchase. For 30 days following its receipt of such Transfer Notice, the Company shall have the option to purchase all or
part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase
all or part of the Offered Shares, it shall give written notice of such election to the Participant within such 30-day period. Within
10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the certificate
or certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly
endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to the Company. Promptly following
receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase
price for such Offered Shares; provided that if the terms of payment set forth in the Transfer Notice were other than cash against
delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice; and provided
further that any delay in making such payment shall not invalidate the Company’s exercise of its option to purchase the Offered
Shares.

 

(c)              Shares
Not Purchased By Company. If the Company does not elect to acquire all of the Offered Shares, the Participant may, within the 30-day
period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares which
the Company has not elected to acquire to the proposed transferee, provided that such transfer shall not be on terms and conditions
more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares transferred
pursuant to this Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee
shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by
all of the terms and conditions of this Section 4.

 

(d)              Consequences
of Non-Delivery. After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company
pursuant to subsection (b) above, the Company shall not pay any dividend to the Participant on account of such Offered Shares or
permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar
as permitted by law, treat the Company as the owner of such Offered Shares.

 

(e)              Exempt
Transactions. The following transactions shall be exempt from the provisions of this Section 4:

 

(1)              any
transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for their benefit;

 

    - 5 -

     

    

 

(2)              any
transfer pursuant to an effective registration statement filed by the Company under the Securities Act of 1933, as amended (the “Securities
Act”); and

 

(3)              the
sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation);

 

provided,
however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first
refusal set forth in this Section 4.

 

(f)              Assignment
of Company Right. The Company may assign its rights to purchase Offered Shares in any particular transaction under this Section 4
to one or more persons or entities.

 

(g)              Termination.
The provisions of this Section 4 shall terminate upon the earlier of the following events:

 

(1)              the
closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed
by the Company under the Securities Act; or

 

(2)              the
sale of all or substantially all of the outstanding shares of capital stock, assets or business of the Company, by merger, consolidation,
sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who
were beneficial owners of the Company’s voting securities immediately prior to such transaction beneficially own, directly or indirectly,
more than 50% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors
of the resulting, surviving or acquiring corporation in such transaction).

 

(h)              No
Obligation to Recognize Invalid Transfer. The Company shall not be required (1) to transfer on its books any of the Shares which
shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner
of such Shares or to pay dividends to any transferee to whom any such Shares shall have been so sold or transferred.

 

(i)              Legends.
The certificate representing Shares shall bear a legend substantially in the following form (in addition to, or in combination with,
any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities):

 

“The
shares represented by this certificate are subject to a right of first refusal in favor of the Company, as provided in a certain stock
option agreement with the Company.”

 

    - 6 -

     

    

 

5.              Agreement
in Connection with Initial Public Offering.

 

The
Participant agrees, in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement
under the Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option
or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer
or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap
or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of shares of Common Stock or other
securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities,
in cash or otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange
Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional 34 days to the
extent requested by the managing underwriters for such offering in order to address NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4) or
any similar successor provision), and (ii) to execute any agreement reflecting clause (i) above as may be requested by the
Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to
the shares of Common Stock or other securities subject to the foregoing restriction until the end of the “lock-up” period.

 

6.              Tax
Matters.

 

(a)              Withholding.
No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision
satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of
this option.

 

(b)              Disqualifying
Disposition. If this option satisfies the requirements to be treated as an incentive stock option under the Code and the Participant
disposes of Shares acquired upon exercise of this option within two years from the Grant Date or one year after such Shares were acquired
pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition.

 

7.              Transfer
Restrictions.

 

(a)              This
option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation
of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable
only by the Participant.

 

(b)              The
Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of this option unless the transferee,
as a condition to such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of
the terms and conditions of Section 4 and Section 5; provided that such a written confirmation shall not be required with respect
to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after
the completion of the lock-up period in connection with the Company’s initial underwritten public offering.

 

8.              Provisions
of the Plan.

 

This
option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is attached
hereto as Exhibit C.

 

[Remainder of Page Intentionally
Left Blank]

 

    - 7 -

     

    

 

Exhibit B

 

Notice
of Stock Option Exercise

 

[DATE]3

 

Xilio Therapeutics, Inc.

828 Winter Street

Waltham, MA 02451 

Attention: [Treasurer]

 

Dear Sir or Madam:

 

I
am the holder of [__________]4 Stock Option granted to me under the Xilio Therapeutics, Inc. (the “Company”)
2020 Stock Incentive Plan on [__________]5 for the purchase of [__________]6 shares of Common Stock of the Company
at a purchase price of $[__________]7 per share.

 

I
hereby exercise my option to purchase [_________]8 shares of Common Stock (the “Shares”), for which I have
enclosed [__________]9 in the amount of [________]10. Please register my stock certificate as follows:

 

	Name(s):	11	
	 	 	 
	 	 	 
	Address:	 	 

 

I
represent, warrant and covenant as follows:

 

1.              I
am purchasing the Shares for my own account for investment only, and not with a view to, or for sale in connection with, any distribution
of the Shares in violation of the Securities Act of 1933 (the “Securities Act”), or any rule or regulation under
the Securities Act.

 

 

3       Enter
date of exercise.

4       Enter
either “an Incentive” or “a Nonstatutory” or both.

5       Enter
the date of grant.

6       Enter
the total number of shares of Common Stock for which the option was granted.

7       Enter
the option exercise price per share of Common Stock.

8       Enter
the number of shares of Common Stock to be purchased upon exercise of all or part of the option.

9       Enter
 “cash”, “personal check” or if permitted by the option or Plan, “stock certificates No. XXXX and XXXX”.

10     Enter
the dollar amount (price per share of Common Stock times the number of shares of Common Stock to be purchased), or the number of shares
tendered. Fair market value of shares tendered, together with cash or check, must cover the purchase price of the shares issued upon
exercise.

11      Enter
name(s) to appear on stock certificate in one of the following formats: (a) your name only (i.e., John Doe); (b) your name and other
name (i.e., John Doe and Jane Doe, Joint Tenants with Right to Survivorship); or for Nonstatutory Stock Options only, (c) a child’s
name, with you as custodian (i.e. Jane Doe, Custodian for Tommy Doe). Note: There may be income and/or gift tax consequences for registering
shares in a child’s name.

 

    - 8 -

     

    

 

2.              I
have had such opportunity as I have deemed adequate to obtain from representatives of the Company such information as is necessary to
permit me to evaluate the merits and risks of my investment in the Company.

 

3.             I
have sufficient experience in business, financial and investment matters to be able to evaluate the risks involved in the purchase of
the Shares and to make an informed investment decision with respect to such purchase.

 

4.              I
can afford a complete loss of the value of the Shares and am able to bear the economic risk of holding such Shares for an indefinite
period.

 

5.              I
understand that (i) the Shares have not been registered under the Securities Act and are “restricted securities” within
the meaning of Rule 144 under the Securities Act, (ii) the Shares cannot be sold, transferred or otherwise disposed of unless
they are subsequently registered under the Securities Act or an exemption from registration is then available; (iii) in any event,
the exemption from registration under Rule 144 will not be available for at least six months and even then will not be available
unless a public market then exists for the Common Stock, adequate information concerning the Company is then available to the public,
and other terms and conditions of Rule 144 are complied with; and (iv) there is now no registration statement on file with
the Securities and Exchange Commission with respect to any stock of the Company and the Company has no obligation or current intention
to register the Shares under the Securities Act.

 

[By
the execution and delivery of this Notice of Stock Option Exercise, I shall be, and hereby agree to be, bound by the (i) Voting
Agreement, dated [__________], 2020, by and among the Company and the other signatories thereto, as amended and/or restated from time
to time (the “Voting Agreement”), as a “Key Holder” and “Stockholder”
(each as defined in the Voting Agreement) for all purposes under the Voting Agreement and (ii) Right of First Refusal and Co-Sale
Agreement, dated [__________], 2020, by and among the Company and the other signatories thereto, as amended and/or restated from time
to time (the “ROFR and Co-Sale Agreement”), as a “Key Holder” (as defined in the ROFR and Co-Sale Agreement)
for all purposes under the ROFR and Co-Sale Agreement. In addition to the foregoing, I shall execute and deliver to the Company
(i) an Adoption Agreement in the form attached to the Voting Agreement, thereby agreeing to be bound by and subject to the terms
of the Voting Agreement as a “Key Holder” and “Stockholder” (each as defined in the Voting Agreement) and (ii) a
counterpart signature page to the ROFR and Co-Sale Agreement, thereby agreeing to be bound by and subject to the terms of the ROFR
and Co-Sale Agreement as a “Key Holder” (as defined in the ROFR and Co-Sale Agreement). I acknowledge and agree that I have
received a copy of the Voting Agreement and the ROFR and Co-Sale Agreement.]12

 

 

12 Include this provision if
the Participant is a 1% stockholder (calculated on a fully diluted basis). In addition, the Participant should receive a copy of the
Voting Agreement and ROFR and Co-Sale Agreement and also execute and deliver the Adoption Agreement pursuant to the terms of the Voting
Agreement and a counterpart signature page to the ROFR and Co-Sale Agreement.

 

    - 9 -

     

    

 

	Very truly yours,	 
	 	 
	 	 

 

    - 10 -

     

    

 

Exhibit C

Xilio
Therapeutics, Inc. 2020 Stock Incentive Plan

 

    - 11 -Exhibit 10.4

 

Xilio
Therapeutics, Inc.

 

Restricted
Stock Agreement

Granted Under 2020 Stock Incentive Plan

 

This Restricted Stock Agreement
(the “Agreement”) is made this [____] day of [_____________], 20[ ], between Xilio Therapeutics, Inc., a Delaware
corporation (the “Company”), and [________________________] (the “Participant”).

 

For valuable consideration,
receipt of which is acknowledged, the parties hereto agree as follows:

 

1.           Purchase
of Shares.

 

The Company shall issue and
sell to the Participant, and the Participant shall purchase from the Company, subject to the terms and conditions set forth in this Agreement
and in the Company’s 2020 Stock Incentive Plan (the “Plan”), [______] shares (the “Shares”)
of common stock, $0.0001 par value, of the Company (“Common Stock”), at a purchase price of $[_____] per share. The
aggregate purchase price for the Shares shall be paid by the Participant by check payable to the order of the Company or such other method
as may be acceptable to the Company. Upon receipt by the Company of payment for the Shares, the Company shall issue to the Participant
one or more certificates in the name of the Participant for that number of Shares purchased by the Participant. The Participant agrees
that the Shares shall be subject to the purchase options set forth in Sections 3 and 6 of this Agreement and the restrictions on
transfer set forth in Section 5 of this Agreement.

 

2.            Certain
Definitions.

 

(a)            [“Cause”
shall exist upon (i) a good faith finding by the Board of Directors of the Company (A) of repeated and willful failure of the
Participant after written notice to perform the Participant’s reasonably assigned duties for the Company, or (B) that the
Participant has engaged in dishonesty, gross negligence or misconduct, which dishonesty, gross negligence or misconduct has had a material
adverse effect on the business affairs of the Company; (ii) the conviction of the Participant of, or the entry of a pleading of
guilty or nolo contendere by the Participant to, any crime involving moral turpitude or any felony; or (iii) a breach by the Participant
of any material provision of any invention and non-disclosure agreement or non-competition and non-solicitation agreement with the Company,
which breach is not cured within ten days written notice thereof.] 1

 

(b)            “Change
in Control” shall mean the sale of all or substantially all of the outstanding shares of capital stock, assets or business of
the Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially
all of the individuals and entities who were beneficial owners of the Company’s voting securities immediately prior to such transaction
beneficially own, directly or indirectly, more than 50% (determined on an as-converted basis) of the outstanding securities entitled to
vote generally in the election of directors of the resulting, surviving or acquiring corporation in such transaction).

 

 

1
Delete definition if acceleration is not being used.

 

    

     

    

 

(c)            [“Good
Reason” shall exist upon (i) the relocation of the Company’s offices such that the Participant's daily commute is
increased by at least thirty (30) miles each way without the written consent of the Participant; (ii) material reduction of
the Participant’s annual base salary without the prior consent of the Participant (other than in connection with, and substantially
proportionate to, reductions by the Company of the annual base salary of more than fifty percent (50%) of its employees); or (iii) material
diminution in the Participant’s duties, authority or responsibilities without the prior consent of the Participant, other than changes
in duties, authority or responsibilities resulting from the Participant’s misconduct; provided, however, that any reduction
in duties, authority or responsibilities or reduction in the level of management to which the Participant reports resulting solely
from a Change in Control which results in the Company being acquired by and made a part of a larger entity shall not constitute Good Reason;
provided, further, however, that no such events or conditions shall constitute Good Reason unless (x) the Participant gives
the Company a written notice of termination for Good Reason not more than ninety (90) days after the initial existence of the event
or condition, (y) the grounds for termination, if susceptible to correction, are not corrected by the Company within thirty (30) days
of its receipt of such notice and (z) the Participant’s termination of Service occurs within six months following the Company’s
receipt of such notice.]2

 

(d)            “Service”
shall mean employment by or the provision of services to the Company or a parent or subsidiary thereof as an advisor, officer, consultant
or member of the Board of Directors.

 

(e)            “Vesting
Commencement Date” shall mean [_________________].

 

3.            Purchase
Option.

 

(a)            In
the event that the Participant ceases to provide Service for any reason or no reason, with or without Cause, prior to [_________]3,
the Company shall have the right and option (the “Purchase Option”) to purchase from the Participant, for a sum of
$0.0001 per share (the “Option Price”), some or all of the Shares as set forth herein.

 

(b)            [________________________________________________________]
4.

 

(c)            [[________________________________________________________]
5.]

 

4.            Exercise
of Purchase Option and Closing.

 

(a)            The
Company may exercise the Purchase Option by delivering or mailing to the Participant (or the Participant’s estate), within 180 days
after the termination of the Service of the Participant, a written notice of exercise of the Purchase Option. Such notice shall specify
the number of Shares to be purchased. If and to the extent the Purchase Option is not so exercised by the giving of such a notice within
such 180-day period, the Purchase Option shall automatically expire and terminate effective upon the expiration of such 180-day period.

 

 

2
Delete definition if acceleration is not being used.

3
The end of the vesting period as established in Section 3(b).

4
Vesting schedule to be completed.

5
Acceleration terms (if applicable) to be completed.

 

    - 2 -

     

    

 

(b)            Within
ten (10) days after delivery to the Participant of the Company’s notice of the exercise of the Purchase Option pursuant to
subsection (a) above, the Participant (or the Participant’s estate) shall, pursuant to the provisions of the Joint Escrow
Instructions referred to in Section 8 below, tender to the Company at its principal offices the certificate or certificates representing
the Shares that the Company has elected to purchase in accordance with the terms of this Agreement, duly endorsed in blank or with duly
endorsed stock powers attached thereto, all in form suitable for the transfer of such Shares to the Company. Promptly following its receipt
of such certificate or certificates, the Company shall pay to the Participant the aggregate Option Price for such Shares (provided that
any delay in making such payment shall not invalidate the Company’s exercise of the Purchase Option with respect to such Shares).

 

(c)            After
the time at which any Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above,
the Company shall not pay any dividend to the Participant on account of such Shares or permit the Participant to exercise any of the privileges
or rights of a stockholder with respect to such Shares, but shall, in so far as permitted by law, treat the Company as the owner of such
Shares.

 

(d)            The
Option Price may be payable, at the option of the Company, in cancellation of all or a portion of any outstanding indebtedness of the
Participant to the Company or in cash (by check) or both.

 

(e)            The
Company shall not purchase any fraction of a Share upon exercise of the Purchase Option, and any fraction of a Share resulting from a
computation made pursuant to Section 3 of this Agreement shall be rounded to the nearest whole Share (with any one-half Share being
rounded upward).

 

(f)             The
Company may assign its Purchase Option to one or more persons or entities.

 

5.            Restrictions
on Transfer.

 

(a)            The
Participant shall not sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation of law or otherwise (collectively
 “transfer”) any Shares, or any interest therein, that are subject to the Purchase Option, except that the Participant
may transfer such Shares (i) to or for the benefit of any spouse, children, parents, uncles, aunts, siblings, grandchildren and any
other relatives approved by the Board of Directors (collectively, “Approved Relatives”) or to a trust established solely
for the benefit of the Participant and/or Approved Relatives, provided that such Shares shall remain subject to this Agreement
(including without limitation the restrictions on transfer set forth in this Section 5, the Purchase Option and the right of first
refusal set forth in Section 6) and such permitted transferee shall, as a condition to such transfer, deliver to the Company a written
instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement or (ii) as part of
the sale of all or substantially all of the shares of capital stock of the Company (including pursuant to a merger or consolidation),
provided that, in accordance with the Plan, the securities or other property received by the Participant in connection with such
transaction shall remain subject to this Agreement.

 

    - 3 -

     

    

 

(b)            The
Participant shall not transfer any Shares, or any interest therein, that are no longer subject to the Purchase Option, except in accordance
with Section 6 below.

 

6.             Right
of First Refusal.

 

(a)            If
the Participant proposes to transfer any Shares that are no longer subject to the Purchase Option (either because they are free from the
Purchase Option pursuant to Section 3 or because the Purchase Option expired unexercised pursuant to Section 4), then the Participant
shall first give written notice of the proposed transfer (the “Transfer Notice”) to the Company. The Transfer Notice
shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the “Offered Shares”),
the price per share and all other material terms and conditions of the transfer.

 

(b)            For
30 days following its receipt of such Transfer Notice, the Company shall have the option to purchase all or part of the Offered Shares
at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered
Shares, it shall give written notice of such election to the Participant within such 30-day period. Within 10 days after the Participant’s
receipt of such notice, the Participant shall tender to the Company at its principal offices the certificate or certificates representing
the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached
thereto, all in a form suitable for transfer of the Offered Shares to the Company. Promptly following receipt of such certificate or
certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares;
provided that if the terms of payment set forth in the Transfer Notice were other than cash against delivery, the Company may
pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice; and provided further
that any delay in making such payment shall not invalidate the Company’s exercise of its option to purchase the Offered Shares.

 

(c)            If
the Company does not elect to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration
of the option granted to the Company under subsection (b) above, transfer the Offered Shares which the Company has not elected to
acquire to the proposed transferee, provided that such transfer shall not be on terms and conditions more favorable
to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares transferred pursuant
to this Section 6 shall remain subject to this Agreement (including without limitation the restrictions on transfer set forth in
Section 5 and the right of first refusal set forth in this Section 6) and such transferee shall, as a condition to such transfer,
deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this
Agreement.

 

(d)            After
the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above,
the Company shall not pay any dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any
of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company
as the owner of such Offered Shares.

 

    - 4 -

     

    

 

(e)            The
following transactions shall be exempt from the provisions of this Section 6:

 

(1)            a
transfer of Shares to or for the benefit of any Approved Relatives, or to a trust established solely for the benefit of the Participant
and/or Approved Relatives;

 

(2)            any
transfer pursuant to an effective registration statement filed by the Company under the Securities Act of 1933, as amended (the “Securities
Act”); and

 

(3)             the
sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation);

 

provided,
however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to this Agreement (including
without limitation the restrictions on transfer set forth in Section 5 and the right of first refusal set forth in this Section 6)
and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee
shall be bound by all of the terms and conditions of this Agreement.

 

(f)            The
Company may assign its rights to purchase Offered Shares in any particular transaction under this Section 6 to one or more persons
or entities.

 

(g)            The
provisions of this Section 6 shall terminate upon the earlier of the following events:

 

(1)             the
closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed
by the Company under the Securities Act; or

 

(2)            a
Change in Control.

 

(h)            The
Company shall not be required (1) to transfer on its books any of the Shares which shall have been sold or transferred in violation
of any of the provisions set forth in this Agreement, or (2) to treat as owner of such Shares or to pay dividends to any transferee
to whom any such Shares shall have been so sold or transferred.

 

7.            Agreement
in Connection with Initial Public Offering.

 

The Participant agrees, in
connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement under the Securities
Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly
or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock
or (b) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership
of shares of Common Stock, whether any transaction described in clause (a) or (b) is to be settled by delivery of shares of
Common Stock or other securities, in cash or otherwise, during the period beginning on the date of the filing of such registration statement
with the Securities and Exchange Commission and ending 180 days from the date of the final prospectus relating to the offering (plus up
to an additional 34 days to the extent requested by the managing underwriters for such offering in order to address NASD Rule 2711(f)(4) or
NYSE Rule 472(f)(4) or any similar successor provision), and (ii) to execute any agreement reflecting clause (i) above
as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions
with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end of the “lock-up”
period.

 

    - 5 -

     

    

 

8.            Escrow.

 

The Participant shall, upon
the execution of this Agreement, execute Joint Escrow Instructions in the form attached to this Agreement as Exhibit A. The
Joint Escrow Instructions shall be delivered to the Secretary of the Company, as escrow agent thereunder. The Participant shall deliver
to such escrow agent a stock assignment duly endorsed in blank, in the form attached to this Agreement as Exhibit B, and hereby
instructs the Company to deliver to such escrow agent, on behalf of the Participant, the certificate(s) evidencing the Shares issued
hereunder. Such materials shall be held by such escrow agent pursuant to the terms of such Joint Escrow Instructions.

 

9.            Restrictive
Legends.

 

All certificates representing
Shares shall have affixed thereto legends in substantially the following form, in addition to any other legends that may be required under
federal or state securities laws:

 

“The shares of stock represented
by this certificate are subject to restrictions on transfer and an option to purchase set forth in a certain Restricted Stock Agreement
between the corporation and the registered owner of these shares (or such owner’s predecessor in interest), and such Agreement is
available for inspection without charge at the office of the Secretary of the corporation.”

 

“The shares represented by this
certificate have not been registered under the Securities Act of 1933, as amended, and may not be sold, transferred or otherwise disposed
of in the absence of an effective registration statement under such Act or an opinion of counsel satisfactory to the corporation to the
effect that such registration is not required.”

 

    - 6 -

     

    

 

10.          Provisions
of the Plan.

 

This Agreement is subject
to the provisions of the Plan, a copy of which is furnished to the Participant with this Agreement.

 

11.          Investment
Representations.

 

The Participant represents,
warrants and covenants as follows:

 

(a)            The
Participant is purchasing the Shares for Participant’s own account for investment only, and not with a view to, or for sale in connection
with, any distribution of the Shares in violation of the Securities Act, or any rule or regulation under the Securities Act.

 

(b)            The
Participant has had such opportunity as Participant has deemed adequate to obtain from representatives of the Company such information
as is necessary to permit him to evaluate the merits and risks of Participant’s investment in the Company.

 

(c)            The
Participant has sufficient experience in business, financial and investment matters to be able to evaluate the risks involved in the purchase
of the Shares and to make an informed investment decision with respect to such purchase.

 

(d)            The
Participant can afford a complete loss of the value of the Shares and is able to bear the economic risk of holding such Shares for an
indefinite period.

 

(e)            The
Participant understands that (i) the Shares have not been registered under the Securities Act and are “restricted securities”
within the meaning of Rule 144 under the Securities Act; (ii) the Shares cannot be sold, transferred or otherwise disposed of
unless they are subsequently registered under the Securities Act or an exemption from registration is then available; (iii) in any
event, the exemption from registration under Rule 144 will not be available for at least one year and even then will not be available
unless a public market then exists for the Common Stock, adequate information concerning the Company is then available to the public,
and other terms and conditions of Rule 144 are complied with; and (iv) there is now no registration statement on file with the
Securities and Exchange Commission with respect to any stock of the Company and the Company has no obligation or current intention to
register the Shares under the Securities Act.

 

12.         Withholding
Taxes; Section 83(b) Election.

 

(a)            The
Participant acknowledges and agrees that the Company has the right to deduct from payments of any kind otherwise due to the Participant
any federal, state or local taxes of any kind required by law to be withheld with respect to the purchase of the Shares by the Participant
or the lapse of the Purchase Option.

 

(b)            The
Participant has reviewed with the Participant’s own tax advisors the federal, state, local and foreign tax consequences of this
investment and the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements
or representations of the Company or any of its agents. The Participant understands that the Participant (and not the Company) shall be
responsible for the Participant’s own tax liability that may arise as a result of this investment or the transactions contemplated
by this Agreement. The Participant understands that it may be beneficial in many circumstances to elect to be taxed at the time the Shares
are granted by the Company rather than when and as the Company’s Purchase Option expires by filing an election under Section 83(b) of
the Internal Revenue Code of 1986 with the I.R.S. within 30 days from the date of grant by the Company.

 

    - 7 -

     

    

 

THE PARTICIPANT ACKNOWLEDGES
THAT IT IS SOLELY THE PARTICIPANT’S RESPONSIBILITY AND NOT THE COMPANY’S TO FILE TIMELY THE ELECTION UNDER SECTION 83(b),
EVEN IF THE PARTICIPANT REQUESTS THE COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON THE PARTICIPANT’S BEHALF.

 

13.          Miscellaneous.

 

(a)            No
Rights to Employment. The Participant acknowledges and agrees that the vesting of the Shares pursuant to Section 3 hereof is
earned only by the Participant’s continuous Service (not through the act of being hired or purchasing the Shares hereunder). The
Participant further acknowledges and agrees that the transactions contemplated hereunder and the vesting schedule set forth herein do
not constitute an express or implied promise of continued engagement as an employee or consultant for the vesting period, for any period,
or at all.

 

(b)            Severability.
The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision
of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.

 

(c)            Waiver.
Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance,
by the Board of Directors of the Company.

 

(d)            Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs,
executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Sections 5
and 6 of this Agreement.

 

(e)            Notice.
All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after
deposit in the United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the
address shown beneath his or her or its respective signature to this Agreement, or at such other address or addresses as either party
shall designate to the other in accordance with this Section 13(e).

 

(f)            Pronouns.
Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms,
and the singular form of nouns and pronouns shall include the plural, and vice versa.

 

    - 8 -

     

    

 

(g)            Entire
Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and
understandings, relating to the subject matter of this Agreement.

 

(h)            Amendment.
This Agreement may be amended or modified only by a written instrument executed by both the Company and the Participant.

 

(i)             Governing
Law. This Agreement shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware without
regard to any applicable conflict of law principles.

 

(j)             Participant’s
Acknowledgments. The Participant acknowledges that he or she: (i) has read this Agreement; (ii) has been represented in
the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily
declined to seek such counsel; (iii) understands the terms and consequences of this Agreement; (iv) is fully aware of the legal
and binding effect of this Agreement; and (v) understands that the law firm of WilmerHale is acting as counsel to the Company in
connection with the transactions contemplated by the Agreement, and is not acting as counsel for the Participant.

 

[Remainder of Page Intentionally Left Blank]

 

    - 9 -

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed the Restricted Stock Agreement as of the date and year first above written. The Participant hereby agrees to the
terms and conditions thereof. The Participant hereby acknowledges receipt of a copy of the Company’s 2020 Stock Incentive Plan.

 

	 	COMPANY:
	 	 
	 	Xilio Therapeutics, Inc.
	 	 	By:	            
	 	 	Name:	                                             
	 	 	Title:	 

 

	 	Address:	[                                                                                                          ]
	 	 	[                                                                                                          ]

 

	 	PARTICIPANT:
	 	 
	 	By:	 
	 	 	Name:	         

 

	 	Address:	[                                                                                                          ]
	 	 	[                                                                                                          ]

 

	 	SPOUSAL CONSENT:
	 	 
	 	By:	 
	 	 	Name:	         

 

	 	Address:	[                                                                                                          ]
	 	 	[                                                                                                          ]

 

Signature
Page to Restricted Stock Agreement

GRANTED
UNDER STOCK INCENTIVE PLAN

 

     

     

    

 

Exhibit A

 

Joint
Escrow Instructions

 

     - 11 -

     

    

 

Xilio
Therapeutics, Inc. Joint Escrow Instructions

 

[___________, 20__]

 

Xilio Therapeutics, Inc.

828 Winter Street

Waltham, MA 02451

 

Attention: Secretary

 

Dear Secretary:

 

As Escrow Agent for Xilio
Therapeutics, Inc., a Delaware corporation (the “Company”), and its successors in interest under the Restricted
Stock Agreement (the “Agreement”) of even date herewith, to which a copy of these Joint Escrow Instructions is attached,
and the undersigned person (“Holder”), you are hereby authorized and directed to hold the documents delivered to you
pursuant to the terms of the Agreement in accordance with the following instructions:

 

1.            Appointment.
Holder irrevocably authorizes the Company to deposit with you any certificates evidencing Shares (as defined in the Agreement) to be held
by you hereunder and any additions and substitutions to said Shares. For purposes of these Joint Escrow Instructions, “Shares”
shall be deemed to include any additional or substitute property. Holder does hereby irrevocably constitute and appoint you as his or
her attorney-in-fact and agent for the term of this escrow to execute with respect to such Shares all documents necessary or appropriate
to make such Shares negotiable and to complete any transaction herein contemplated. Subject to the provisions of this Section 1 and
the terms of the Agreement, Holder shall exercise all rights and privileges of a stockholder of the Company while the Shares are held
by you.

 

2.            Closing
of Purchase.

 

(a)            Upon
any purchase by the Company of the Shares pursuant to the Agreement, the Company shall give to Holder and you a written notice specifying
the number of Shares to be purchased, the purchase price for the Shares, as determined pursuant to the Agreement, and the time for a closing
hereunder (the “Closing”) at the principal office of the Company. Holder and the Company hereby irrevocably authorize
and direct you to close the transaction contemplated by such notice in accordance with the terms of said notice.

 

(b)            At
the Closing, you are directed (i) to date the stock assignment form or forms necessary for the transfer of the Shares, (ii) to
fill in on such form or forms the number of Shares being transferred, and (iii) to deliver the same, together with the certificate
or certificates evidencing the Shares to be transferred, to the Company against the simultaneous delivery to you of the purchase price
for the Shares being purchased pursuant to the Agreement.

 

3.            Withdrawal.
The Holder shall have the right to withdraw from this escrow any Shares as to which the Purchase Option (as defined in the Agreement)
has terminated or expired.

 

     

     

    

 

4.            Duties
of Escrow Agent.

 

(a)            Your
duties hereunder may be altered, amended, modified or revoked only by a writing signed by all of the parties hereto.

 

(b)            You
shall be obligated only for the performance of such duties as are specifically set forth herein and may rely and shall be protected in
relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the
proper party or parties. You shall not be personally liable for any act you may do or omit to do hereunder as Escrow Agent or as attorney-in-fact
of Holder while acting in good faith and in the exercise of your own good judgment, and any act done or omitted by you pursuant to the
advice of your own attorneys shall be conclusive evidence of such good faith.

 

(c)            You
are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any other person or entity,
excepting only orders or process of courts of law, and are hereby expressly authorized to comply with and obey orders, judgments or decrees
of any court. If you are uncertain of any actions to be taken or instructions to be followed, you may refuse to act in the absence of
an order, judgment or decrees of a court. In case you obey or comply with any such order, judgment or decree of any court, you shall not
be liable to any of the parties hereto or to any other person or entity, by reason of such compliance, notwithstanding any such order,
judgment or decree being subsequently reversed, modified, annulled, set aside, vacated or found to have been entered without jurisdiction.

 

(d)            You
shall not be liable in any respect on account of the identity, authority or rights of the parties executing or delivering or purporting
to execute or deliver the Agreement or any documents or papers deposited or called for hereunder.

 

(e)            You
shall be entitled to employ such legal counsel and other experts as you may deem necessary properly to advise you in connection with your
obligations hereunder and may rely upon the advice of such counsel.

 

(f)            Your
rights and responsibilities as Escrow Agent hereunder shall terminate if (i) you cease to be Secretary of the Company or (ii) you
resign by written notice to each party. In the event of a termination under clause (i), your successor as Secretary shall become
Escrow Agent hereunder; in the event of a termination under clause (ii), the Company shall appoint a successor Escrow Agent hereunder.

 

(g)            If
you reasonably require other or further instruments in connection with these Joint Escrow Instructions or obligations in respect hereto,
the necessary parties hereto shall join in furnishing such instruments.

 

(h)            It
is understood and agreed that if you believe a dispute has arisen with respect to the delivery and/or ownership or right of possession
of the securities held by you hereunder, you are authorized and directed to retain in your possession without liability to anyone all
or any part of said securities until such dispute shall have been settled either by mutual written agreement of the parties concerned
or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been
perfected, but you shall be under no duty whatsoever to institute or defend any such proceedings.

 

     

     

    

 

(i)             These
Joint Escrow Instructions set forth your sole duties with respect to any and all matters pertinent hereto and no implied duties or obligations
shall be read into these Joint Escrow Instructions against you.

 

(j)            The
Company shall indemnify you and hold you harmless against any and all damages, losses, liabilities, costs, and expenses, including attorneys’
fees and disbursements, (including without limitation the fees of counsel retained pursuant to Section 4(e) above, for anything
done or omitted to be done by you as Escrow Agent in connection with this Agreement or the performance of your duties hereunder, except
such as shall result from your gross negligence or willful misconduct.

 

5.            Notice.
Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery or upon
deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other
parties thereunto entitled at the following addresses, or at such other addresses as a party may designate by ten days’ advance
written notice to each of the other parties hereto.

 

	COMPANY:	Notices to the Company shall be sent to the address set forth in the salutation hereto, Attn: President
	 	 
	HOLDER:	Notices to Holder shall be sent to the address set forth below Holder's signature below.
	 	 
	ESCROW AGENT:	Notices to the Escrow Agent shall be sent to the address set forth in the salutation hereto.

 

6.            Miscellaneous.

 

(a)            By
signing these Joint Escrow Instructions, you become a party hereto only for the purpose of said Joint Escrow Instructions, and you do
not become a party to the Agreement.

 

(b)            This
instrument shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.

 

[Remainder of Page Intentionally Left Blank]

 

     

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed these Joint Escrow Instructions as of the day and year first above written.

 

	 	Very truly yours,
	 	 
	 	COMPANY:
	 	 
	 	Xilio Therapeutics, Inc.
	 	 
	 	 	By:	            
	 	 	Name:	                                             
	 	 	Title:	 

 

	 	HOLDER:
	 	 
	 	By:	 
	 	 	Name:	         

 

	 	Address:	[                                                                                                          ]
	 	 	[                                                                                                          ]

 

	 	ESCROW AGENT:
	 	 
	 	By:	 
	 	 	Name:	         
	 	 	Title:	Secretary

 

Signature
Page to JOINT ESCROW INSTRUCTIONS

 

     

     

    

 

Exhibit B

 

Stock
Assignment Separate from Certificate

 

     

     

    

 

Stock
Assignment Separate from Certificate

 

FOR VALUE RECEIVED, I
hereby sell, assign and transfer unto ____________________________________ (_________) shares of Common Stock, $0.0001 par value per
share, of Xilio Therapeutics, Inc. (the “Corporation”) standing in my name on the books of the Corporation represented
by Certificate(s) Number __________ herewith, and do hereby irrevocably constitute and appoint Wilmer Cutler Pickering Hale and Dorr
LLP attorney to transfer the said stock on the books of the Corporation with full power of substitution in the premises.

 

Dated:                                               

 

	 	PARTICIPANT:
	 	 
	 	 
	 	[Name]
	 	 
	 	 
	 	Name of Spouse (if any):

 

Instructions
to Participant: Please do not fill in any blanks other than the signature line(s). The purpose of the Stock Assignment
Separate from Certificate is to enable the Company to acquire the Shares upon exercise of its Right of First Refusal and/or Purchase Option
without requiring additional signatures on the part of the Participant or Participant’s spouse, if any. The signature(s) to
this assignment must correspond with the name as written upon the face of the certificate, in every particular, without alteration, enlargement,
or any change whatever.

 

     

     

    

 

Notice
on 83(b) Elections

 

IF YOU WISH TO MAKE A SECTION 83(B) ELECTION,
THE FILING OF SUCH ELECTION IS YOUR RESPONSIBILITY.

 

THE FORM FOR MAKING THIS SECTION 83(B) ELECTION
IS ATTACHED TO THIS AGREEMENT. YOU MUST FILE THIS FORM WITHIN 30 DAYS OF THE GRANT DATE.

 

YOU (AND NOT THE COMPANY, ANY OF ITS AGENTS
OR ANY OTHER PERSON) SHALL BE SOLELY RESPONSIBLE FOR FILING SUCH FORM WITH THE IRS, EVEN IF YOU REQUEST THE COMPANY, ITS AGENTS
OR ANY OTHER PERSON TO MAKE THIS FILING ON YOUR BEHALF AND EVEN IF THE COMPANY, ANY OF ITS AGENTS OR ANY OTHER PERSON HAS PREVIOUSLY MADE
THIS FILING ON YOUR BEHALF.

 

The 83(b) election
should be filed by mailing a signed election form by certified mail, return receipt requested to the IRS Service Center where you file
your tax returns. See www.irs.gov.

 

     

     

    

 

Section 83(b) Election

 

The undersigned hereby makes an election pursuant
to Section 83(b) of the Internal Revenue Code of 1986, as amended, with respect to the property described below and supplies
the following information in accordance with Treas. Reg. § 1.83-2:

 

		1.	The name, address, and taxpayer identification number of the undersigned are:

 

[Name]

[Address]

[City, State Zip]

 

Taxpayer Identification Number:                                               

 

		2.	The property with respect to which this election is being made is [______] shares of common stock, $0.0001
par value per share, of Xilio Therapeutics, Inc., a Delaware corporation (the “Company”).

 

		3.	The date on which the property was transferred or the date on which the restrictions on such property
were imposed, whichever is later, is _________________, 20[__] and the taxable year for which this election is being made is the calendar
year 20[__].

 

		4.	The property is subject to vesting provisions and may be forfeited under the terms of a stock restriction
agreement executed between the undersigned and the Company.

 

		5.	The fair market value of the property at the time of the transfer or the date on which the restrictions
on such property were imposed, whichever is later, (determined without regard to any lapse restriction, as defined in Treas. Reg. §
1.83-3(i)) is $[__________], equal to a fair market value of $[__________] per share.

 

		6.	The amount paid for the property by the undersigned is $[__________], equal to a purchase price of $[__________] per share.

 

		7.	This statement is executed on _________________, 20[__].

 

In accordance with Treas. Reg. § 1.83-2(d) & (e)(7),
a copy of this statement has been furnished to the Company.

 

	 	 	 
	Signature of Taxpayer	 	Signature of Spouse (if any)

 

     

     

    

 

Section 83(b) Election

 

Background
Information

 

Section 83(b) of
the Internal Revenue Code permits persons who receive restricted property, such as restricted stock, in connection with the performance
of services to include the value of such property in their gross income for the year the property is received. Such persons who purchase
stock of the company subject to a stock restriction agreement providing for the vesting of such stock over a period of time are entitled
to make this election. Any person who makes a timely Section 83(b) election will recognize compensation income on the date of
grant (the date listed in item 3 of the election form) equal to the difference, if any, between the fair market value of the stock and
the amount paid for the stock. A person who pays taxes in connection with an election and subsequently forfeits the stock, however, will
not receive a refund or other tax benefit for the taxes previously paid.

 

Any person who does not make
the election will be required to include the value of the stock in gross income in the year in which the stock vests. In particular, when
the stock vests, the person will recognize compensation income in an amount equal to the difference between the fair market value of the
stock on the vesting date and the amount paid for the stock. As a result, if the value of the stock increases, a person who does not make
a timely Section 83(b) election will have compensation income at the time each installment of stock vests.

 

Each person should consult
with his or her tax or legal advisor regarding the advisability and timing of filing the election. The original, signed and dated Section 83(b) election
must be filed within 30 days of the grant date but may be filed prior to the grant date. The election should be filed by certified
mail, return receipt requested, with the Internal Revenue Service at the service center where the electing person ordinarily files his
or her annual tax return. A copy of the Section 83(b) election, as filed, must be returned to the company. A copy of the Section 83(b) election
must also be included with the person’s federal income tax return for the year of grant (each person should check with his or her
tax preparer regarding this and any state, local, foreign or other filing requirements).

 

Please also note that
the certified mailing receipt for the Section 83(b) election should be retained. This receipt is essential if the Internal
Revenue Service does not receive the Section 83(b) election and challenges the election.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]